Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current Assets
Cash	$ 2,332,068	$ 3,026,569
Advances on research and development contract services	650,275	328,844
Prepaid insurance	192,691	372,350
Prepaid expenses	18,430	10,000
Total current assets	3,193,464	3,737,763
Total assets	3,193,464	3,737,763
Current Liabilities
Accounts payable and accrued expenses	231,872	360,662
Research and development contract liabilities	44,980
Accrued legal settlement		414,989
Warrant liability	7,655	55,751
Total current liabilities	284,507	831,402
Total liabilities	284,507	831,402
Commitments and Contingencies
Stockholders’ Equity
Preferred Stock, $0.001 par value per share; 20,000,000 shares authorized; none issued or outstanding at June 30, 2024 and December 31, 2023
Common stock, $0.001 par value per share; 100,000,000 shares authorized; 1,315,489 and 534,238 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	1,315	534
Additional paid-in capital	85,466,303	83,814,785
Accumulated deficit	(82,558,661)	(80,908,958)
Total stockholders’ equity	2,908,957	2,906,361
Total liabilities and stockholders’ equity	$ 3,193,464	$ 3,737,763